Sub-optimal prescribing in an adult community mental health service: Prevalence and determinants

Psychiatric Bulletin

Volumn 27, Issue 7, 2003, Pages 266-270

  Meagher, David ^a   Moran, Maria ^b  

^a St Anne's Day Hospital   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; HALOPERIDOL; HYPNOTIC AGENT; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE; SULPIRIDE; THIORIDAZINE; TRIFLUOPERAZINE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL PRACTICE; COMMUNITY MENTAL HEALTH; COMPARATIVE STUDY; CONSULTATION; CONTROLLED STUDY; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE QUALITY; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH SERVICE; PHYSICIAN; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; QUALITATIVE ANALYSIS; REGRESSION ANALYSIS; SCORING SYSTEM;

EID: 0038693224     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.27.7.266     Document Type: Article

References (20)

1. Bazire, S. (2001) Psychotropic Drug Directory. The Professionals Pocket Handbook and Aide Memoire. Bath: Bath Press.
2. Centorrino, P., Eakin, M., Bahk, W. M., et al (2002) Inpatient antipsychotic drug use in 1998, 1993 and 1989. American Journal of Psychiatry, 159, 1932-1935.
3. Department of Health and Children (Republic of Ireland) (2002) Report of the Benzodiazepine Committee. Dublin: Government Publications.
4. Eagles, J. M., McCann, I., MacLeod, I. N., et al (2000) Lithium monitoring before and after the distribution of clinical practice guidelines. Acta Psychiatrica Scandinavica, 101, 349-353.
5. Harrington, M., Lelliott, P., Paton, C., et al (2002a) The results of a multicentre audit of the prescribing of antipsychotic drugs for in-patients in the UK. Psychiatric Bulletin, 26, 414-418.
6. Harrington, M., Lelliott, P., Paton, C., et al (2002b) Variation between services in polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patients. Psychiatric Bulletin, 26, 418-421.
7. Kelly, C., McCreadle, R. G., MacEwen, T., et al (1998) Nithsdale schizophrenia surveys 17: Fifteen year review. British Journal of Psychiatry, 172, 513-518.
8. Lelliott, P., Paton, C., Harrington, M., et al (2002) The influence of patient variables on polypharmacy and combined high dose of antipsychotic drugs prescribed for in-patients. Psychiatric Bulletin, 26, 411-414.
9. Mackay, A. V. P. (1994) High-dose antipsychotic medication. Advances in Psychiatric Treatment, 1, 16-23.
10. Marken, P. A., Stoner, S. C., Bunker, M. T. (1996) Anticholinergic drug abuse and misuse. CNS Drugs, 5, 190-199.
11. O'Callaghan, R. (2001) Irish doctors fight plans to curb Valium. Sunday Times (news section), Nov 25.
12. Reilly, J. G., Avis, S. A., Ferrier, I. N., et al (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet, 355, 1048-1052.
13. Royal Pharmaceutical Society of Great Britain (2002) British National Formulary.
14. Stahl, S. (2000) Essential Psychopharmacology. Neuroscientific Basis and Practical Applications, 2nd ed. Cambridge: Cambridge University Press.
15. Steele, J., Duncan, J. & Short, A. (2000) An audit of anti-muscarinic drug-use at the state hospital. Psychiatric Bulletin, 24, 61-64.
16. Taylor, D. (2002) Antipsychotic prescribing - Time to review practice. Psychiatric Bulletin, 26, 401-402.
17. Taylor, D., Mir, S. & Kerwin, R. (2000) Prescribing in schizophrenia. Evaluating the effect of introducing a new treatment protocol. Psychiatric Bulletin, 24, 106-108.
18. Taylor, D., McConnell, D., McConnell, H., et al (2001) The Maudsley Prescribing Guidelines, 6th Edition. London: Martin Dunitz.
19. World Health Organization (1990) Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. A consensus statement. British Journal of Psychiatry, 156, 412.
20. --- (1993) The ICD-10 Classification of Mental and Behavioural Disorders. Geneva: World Health Organization.